| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.2 | 3e-09 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.27 | 8e-08 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | -0.16 | 2e-07 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.19 | 7e-06 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.15 | 1e-05 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | -0.14 | 4e-05 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | -0.12 | 5e-05 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | -0.12 | 6e-05 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | -0.13 | 7e-05 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | -0.12 | 9e-05 |